 | Up a level |
Journal Article
Fischer, Kirsten, Fink, Anna-Maria, Bishop, Helen, Dixon, Mark, Bahlo, Jasmin, Chol, Michael Y., Weinkove, Robert 
ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Sr., Kutsch, Nadine, Tausch, Eugen, Ritgen, Matthias, Humerickhouse, Rod A., Humphrey, Kathryn, Wenger, Michael K., Goede, Valentin, Eichhorst, Barbara, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Kipps, Thomas J. and Hallek, Michael
(2015).
Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase Ill Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions.
Blood, 126 (23).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Goede, Valentin, Fischer, Kirsten, Raymonde, Busch, Ulrich, Jaeger, Dilhuydy, Marie-Sarah, Wickham, Nicholas, De Guibert, Sophie, Fink, Anna Maria, Hagist, Susanne, Pflug, Natali, Bahlo, Jasmin, Kranz, Gabriele, Bieska, Gabriel, Humphrey, Kathryn, Bishop, Helen, Wenger, Michael and Hallek, Michael (2010). Chemoimmunotherapy with Chlorambucil and the Type II CD20-Antibody GA101 In Patients with Chronic Lymphocytic Leukemia and Comorbidity: Results of the Run-In Phase of the CLL11 (BO21004) Trial. Blood, 116 (21). S. 597 - 598. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971